Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TETRAFERRIC TRICITRATE DECAHYDRATE vs TEZEPELUMAB-EKKO: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TETRAFERRIC TRICITRATE DECAHYDRATE vs TEZEPELUMAB-EKKO: Safety Overview

Metric TETRAFERRIC TRICITRATE DECAHYDRATE TEZEPELUMAB-EKKO
Total FAERS Reports 1,663 4,398
Deaths Reported 200 190
Death Rate 12.0% 4.3%
Hospitalizations 220 798
Average Patient Age 60.4 yrs 56.9 yrs
% Female Patients 43.9% 74.5%
Manufacturer Akebia Therapeutics, Inc. N/A
Route ORAL N/A
Marketing Status N/A Prescription